以弥漫性肺泡出血为主要表现的多发性肌炎伴多脏器功能障碍综合征1例

关云艳, 吴锡平, 王倩, 等. 以弥漫性肺泡出血为主要表现的多发性肌炎伴多脏器功能障碍综合征1例[J]. 临床急诊杂志, 2022, 23(1): 72-75. doi: 10.13201/j.issn.1009-5918.2022.01.016
引用本文: 关云艳, 吴锡平, 王倩, 等. 以弥漫性肺泡出血为主要表现的多发性肌炎伴多脏器功能障碍综合征1例[J]. 临床急诊杂志, 2022, 23(1): 72-75. doi: 10.13201/j.issn.1009-5918.2022.01.016
GUAN Yunyan, WU Xiping, WANG Qian, et al. Polymyositis presenting as diffuse alveolar hemorrhage and with multiple organ dysfunction syndrome: a case report[J]. J Clin Emerg, 2022, 23(1): 72-75. doi: 10.13201/j.issn.1009-5918.2022.01.016
Citation: GUAN Yunyan, WU Xiping, WANG Qian, et al. Polymyositis presenting as diffuse alveolar hemorrhage and with multiple organ dysfunction syndrome: a case report[J]. J Clin Emerg, 2022, 23(1): 72-75. doi: 10.13201/j.issn.1009-5918.2022.01.016

以弥漫性肺泡出血为主要表现的多发性肌炎伴多脏器功能障碍综合征1例

详细信息
    通讯作者: 吴锡平, E-mail: wxwxp@163.com
  • 中图分类号: R593.26

Polymyositis presenting as diffuse alveolar hemorrhage and with multiple organ dysfunction syndrome: a case report

More Information
  • 加载中
  • 图 1  胸部CT在治疗及随访过程中的对比

    图 2  治疗过程中主要异常指标的前后对比

  • [1]

    Alexandre AT, Vale A, Gomes T. Diffuse alveolar hemorrhage: how relevant is etiology?[J]. Sarcoidosis Vasc Diffuse Lung Dis, 2019, 36(1): 47-52.

    [2]

    Zhong Y, Bai W, Xie Q, et al. Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study[J]. Int J Cardiovasc Imaging, 2018, 34(5): 683-693.

    [3]

    Griger Z, Danko K, Bodoki L, et al. Corneal Involvement of Patients with Polymyositis and Dermatomyositis[J]. Ocul Immunol Inflamm, 2020, 28(1): 58-66. doi: 10.1080/09273948.2018.1547407

    [4]

    Kamiya M, Mizoguchi F, Takamura A, et al. A new in vitro model of polymyositis reveals CD8+ T cell invasion into muscle cells and its cytotoxic role[J]. Rheumatology(Oxford), 2020, 59(1): 224-232. doi: 10.1093/rheumatology/kez248

    [5]

    张铭明, 张锐, 杨小珂, 等. 特发性炎性肌病患者酶谱指标、炎症指标、自身抗体水平分析[J]. 检验医学与临床, 2020, 17(6): 731-735. doi: 10.3969/j.issn.1672-9455.2020.06.004

    [6]

    Zhang S, Jia X, Zhang Q, et al. Neutrophil extracellular traps activate lung fibroblast to induce polymyositis-related interstitial lung diseases via TLR9-miR-7-Smad2 pathway[J]. J Cell Mol Med, 2020, 24(2): 1658-1669. doi: 10.1111/jcmm.14858

    [7]

    Matsuda S, Kotani T, Ishida T, et al. Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease[J]. Rheumatology(Oxford), 2020, 59(2): 310-318. doi: 10.1093/rheumatology/kez301

    [8]

    Long K, Danoff SK. Interstitial Lung Disease in Polymyositis and Dermatomyositis[J]. Clin Chest Med, 2019, 40(3): 561-572. doi: 10.1016/j.ccm.2019.05.004

    [9]

    Kishaba T, McGill R, Nei Y, et al. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody[J]. J Med Invest, 2018, 65(3.4): 251-257. doi: 10.2152/jmi.65.251

    [10]

    Mimori T, Nakashima R, Hosono Y. Interstitial lung disease in myositis: clinical subsets, biomarkers, and treatment[J]. Curr Rheumatol Rep, 2012, 14(3): 264-274. doi: 10.1007/s11926-012-0246-6

    [11]

    黄华, 彭晨星, 陈宇彬. 皮肌炎/多发性肌炎死亡危险因素分析[J]. 临床荟萃, 2020, 35(10): 927-930. https://www.cnki.com.cn/Article/CJFDTOTAL-LCFC202010012.htm

    [12]

    Sugiyama Y, Yoshimi R, Tamura M, et al. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease[J]. Arthritis Res Ther, 2018, 20(1): 7. doi: 10.1186/s13075-017-1506-7

    [13]

    Takada K, Katada Y, Ito S, et al. Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial[J]. Rheumatology(Oxford), 2020, 59(5): 1084-1093. doi: 10.1093/rheumatology/kez394

    [14]

    Fukuda M, Mizuno H, Hiramatsu R, et al. A Case Of Thrombotic Microangiopathy Associated With Polymyositis[J]. Clin Nephrol, 2021, 95(6): 339-344. doi: 10.5414/CN109989

    [15]

    Yamada S, Yamashita H, Nakano M, et al. Thrombotic microangiopathy with polymyositis/dermatomyositis: Three case reports and a literature review[J]. Intern Med, 2018, 57(15): 2259-2265. doi: 10.2169/internalmedicine.0512-17

    [16]

    晁琳琳, 刘振宁. 成人溶血尿毒综合征1例[J]. 临床急诊杂志, 2019, 20(10): 814-817. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC201910016.htm

    [17]

    王凯, 高伟波, 朱继红. 血栓性血小板减少性紫癜的研究进展[J]. 临床急诊杂志, 2018, 19(9): 593-598. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC201809003.htm

    [18]

    Kita Y. Post-operative acute exacerbation of interstitial pneumonea associated with amyopathic dermatomyositis[J]. Kyobu Geka, 2010, 63(7): 546-549.

  • 加载中

(2)

计量
  • 文章访问数:  1606
  • PDF下载数:  377
  • 施引文献:  0
出版历程
收稿日期:  2021-07-30
刊出日期:  2022-01-10

目录